Adaptive Biotechnologies Stock Target Price and Analyst Consensus
| ADPT Stock | USD 2.60 0.02 0.78% |
The current analyst and expert consensus on Adaptive Biotechnologies is Strong Buy, with 3 strong buy opinions. The current projected Adaptive Biotechnologies target price consensus is 12.14 with 8 analyst opinions. The most common way Adaptive Biotechnologies analysts use to provide recommendation to the public is financial statements analysis. Many experts also interview Adaptive Biotechnologies executives and customers to further validate their buy or sell advice. Note, the total number of analysts currently providing their opinion is not significant to determine adequate consensus on Adaptive Biotechnologies. We strongly encourage you to use your own analysis of Adaptive Biotechnologies to validate this buy or sell advice. Adaptive Biotechnologies buy-or-sell recommendation module provides average expert sentiment on the projected Adaptive Biotechnologies target price to derive its highest and lowest estimates based on its projected price volatility. Check out Macroaxis Advice on Adaptive Biotechnologies to cross-verify analyst projections. Unlike analyst recommendations, Macroaxis provides advice only from the perspective of investor risk tolerance and investment horizon.
Lowest Forecast 11.05 | Highest Forecast 13.48 | Target Price 12.14 |
Adaptive |
It's important to approach Adaptive Biotechnologies' target price projections with caution. While they can be useful as part of a broader investment strategy, they are inherently speculative and subject to various kinds of risk, including market volatility and unforeseen external factors. Always consider multiple aspects and do your own research when making investment decisions.
Analysts determine stock price targets through various methods, including financial modeling, peer comparison, and company analysis. The stock price target is the analyst's best estimate of the future price of a stock and is used by investors to make investment decisions. However, it is important to note that stock price targets are not guaranteed, and the actual price of a stock can differ significantly from the target due to various factors such as market conditions, economic events, and company developments.
Steps to utilize Adaptive Biotechnologies price targets
Adaptive Biotechnologies' stock target price is an estimate of its future price, usually made by analysts. Using Adaptive Biotechnologies' target price to determine if it is a suitable investment can be done through the following steps:- Look at Adaptive Biotechnologies' target prices provided by various analysts and compare them. This can help you gain a more balanced view of the Stock's potential.
- Look at the analyst's track record to determine if they have a history of accurately predicting stock prices.
- Look at the Company's financials, including revenue, earnings, and debt, to determine if it is in good financial health.
- Consider market conditions. For example, take into account the state of the economy, competition, and regulatory environment, to determine if Adaptive Biotechnologies' stock is likely to perform well.
- Diversify your portfolio and do not rely solely on stock target prices to make investment decisions. Invest in a mix of stocks, bonds, and other assets to manage risk.
Additional Adaptive Biotechnologies Value Projection Modules
Most investment researchers agree that the mispricing and readjustment of any Stock value happens often and is sometimes even predictable, but there is no strong theory explaining why it happens. The current price of Adaptive Biotechnologies is a key component of Adaptive Biotechnologies valuation and have some predictive power on the future returns of a Adaptive Biotechnologies.Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Adaptive Biotechnologies' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Trending Themes
If you are a self-driven investor, you will appreciate our idea-generating investing themes. Our themes help you align your investments inspirations with your core values and are essential building blocks of your portfolios. A typical investing theme is an unweighted collection of up to 20 funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of equities with common characteristics such as industry and growth potential, volatility, or market segment. | Impulse Invested over 100 shares | |
 | Hedge Favorites Invested over 60 shares | |
 | Warren Buffett Holdings Invested few shares | |
Check out Macroaxis Advice on Adaptive Biotechnologies to cross-verify analyst projections. Unlike analyst recommendations, Macroaxis provides advice only from the perspective of investor risk tolerance and investment horizon. You can also try the Positions Ratings module to determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Complementary Tools for Adaptive Stock analysis
When running Adaptive Biotechnologies' price analysis, check to measure Adaptive Biotechnologies' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Adaptive Biotechnologies is operating at the current time. Most of Adaptive Biotechnologies' value examination focuses on studying past and present price action to predict the probability of Adaptive Biotechnologies' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Adaptive Biotechnologies' price. Additionally, you may evaluate how the addition of Adaptive Biotechnologies to your portfolios can decrease your overall portfolio volatility.
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
| Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like |
The data published in Adaptive Biotechnologies' official financial statements usually reflect Adaptive Biotechnologies' business processes, product offerings, services, and other fundamental events. But there are other numbers, ratios, or fundamental indicators derived from these statements that are easier to understand and visualize within the underlying realities that drive quantitative information of Adaptive Biotechnologies. For example, before you start analyzing numbers published by Adaptive accountants, it's critical to develop an understanding of what Adaptive Biotechnologies' liquidity, profitability, and earnings quality are in the context of the Life Sciences Tools & Services space in which it operates.
Please note, the presentation of Adaptive Biotechnologies' financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Adaptive Biotechnologies' management is honest, while the outside auditors are strict and uncompromising. Whatever the case, the imprecision that can be found in Adaptive Biotechnologies' accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of Adaptive Biotechnologies Corp. Please utilize our Beneish M Score to check the likelihood of Adaptive Biotechnologies' management manipulating its earnings.